𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B in the cambridge dialysis and transplant unit 1966–1983

✍ Scribed by J. Nagington; G. M. Sutehall; B. J. Cohen

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
464 KB
Volume
13
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

The results of hepatitis B surveillance of the Cambridge dialysis and transplant units from June 1969 to July 1983 are reported. On admission 34/528 (6.44%) haemodialysis patients had anti-HBc. Preadmission screening excluded 19 HBs Ag carrier patients and two carrier staff. Eight patients became antigenaemic after admission and two others were found to be antigenaemic post-transplantation but pretransplant sera were not available from them. These two had active hepatitis and of the others, seven had asymptomatic carriage and one had acute hepatitis during haemodialysis. Two infected patients were admitted temporarily and one antigenaemic organ donor identified retrospectively. No cross infection occurred on the unit and the only instance of accidental infection of a member of staff was from an outpatient.

📜 SIMILAR VOLUMES

Outcome of liver transplantation for hep
Outcome of liver transplantation for hepatitis B in the United States
✍ W. Ray Kim; John J. Poterucha; Walter K. Kremers; Michael B. Ishitani; E. Rollan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Important innovations, such as hepatitis B immune globulin (HBIG) and lamivudine, have been introduced to the care of patients undergoing liver transplantation (OLT) for viral hepatitis B (HBV) (over the last 15 years). We analyzed survival of OLT recipients with HBV in the United States to examine

Outcomes in liver transplant recipients
Outcomes in liver transplant recipients with hepatitis B virus: Resistance and recurrence patterns from a large transplant center over the last decade
✍ Guy W. Neff; Christopher B. O'Brien; Jose Nery; Norah Shire; Marzia Montalbano; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Hepatitis B virus (HBV) recurrence following liver transplantation (LTx) has been controllable primarily with the use of hepatitis B immune globulin (HBIg) and lamivudine (LAM). However, HBV resistance to LAM and/or HBIg has become an increasing problem prompting the use of newer antiviral agents. T

Patient and graft survival in hepatitis
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States
✍ Mark W. Russo; Joseph Galanko; Kimberly Beavers; Michael W. Fried; Roshan Shrest 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

End stage liver disease from chronic hepatitis C is the leading indication for liver transplantation in the United States. Small studies suggest that recurrent hepatitis C may be more common and occur earlier after living donor liver transplantation compared to deceased donor liver transplantation.

Trends in post–liver transplant survival
Trends in post–liver transplant survival in patients with hepatitis C between 1991 and 2001 in the united states
✍ Paul J. Thuluvath; Karen L. Krok; Dorry L. Segev; Hwan Y. Yoo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

It has been suggested that the post-liver transplantation (LT) survival rate of patients with hepatitis C virus infection (HCV) has declined in recent years. To compare the outcome of LT in patients with HCV at various time intervals between 1991 and 2001, we used United Network for Organ Sharing da